Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novo Nordisk A/S ADR (NVO)

Novo Nordisk A/S ADR (NVO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 237,128,352
  • Shares Outstanding, K 2,354,800
  • Annual Sales, $ 19,448 M
  • Annual Income, $ 6,456 M
  • 60-Month Beta 0.41
  • Price/Sales 12.36
  • Price/Cash Flow 32.38
  • Price/Book 22.36
Trade NVO with:

Options Overview Details

View History
  • Implied Volatility 24.25%
  • Historical Volatility 18.88%
  • IV Percentile 63%
  • IV Rank 35.95%
  • IV High 35.38% on 10/28/20
  • IV Low 18.00% on 05/07/21
  • Put/Call Vol Ratio 0.09
  • Today's Volume 371
  • Volume Avg (30-Day) 784
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 7,632
  • Open Int (30-Day) 11,381

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.81
  • Number of Estimates 2
  • High Estimate 0.82
  • Low Estimate 0.79
  • Prior Year 0.69
  • Growth Rate Est. (year over year) +17.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
98.57 +2.16%
on 09/20/21
104.39 -3.53%
on 08/26/21
-2.92 (-2.82%)
since 08/24/21
3-Month
82.11 +22.64%
on 06/25/21
107.24 -6.10%
on 08/20/21
+18.50 (+22.51%)
since 06/24/21
52-Week
63.22 +59.29%
on 10/30/20
107.24 -6.10%
on 08/20/21
+32.43 (+47.50%)
since 09/24/20

Most Recent Stories

More News
Looking for a Growth Stock? 3 Reasons Why Novo Nordisk (NVO) is a Solid Choice

Novo Nordisk (NVO) possesses solid growth attributes, which could help it handily outperform the market.

NVO : 100.70 (-1.37%)
Here's Why Novo Nordisk (NVO) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

NVO : 100.70 (-1.37%)
Ascendis (ASND) Rallies on First FDA-Approved Drug Skytrofa

Ascendis' (ASND) Skytrofa gets FDA approval for treating growth failure in pediatric patients. The drug is also the first FDA-approved product in the company's portfolio.

PFE : 43.94 (-0.57%)
NVO : 100.70 (-1.37%)
ASND : 164.00 (-2.55%)
IMAB : 68.00 (-3.27%)
3 Big Drug/Biotech Outperformers Worth Keeping an Eye On (Revised)

Eli Lilly (LLY), Pfizer (PFE) and Novo Nordisk (NVO) are three large drugmakers that have outperformed the industry and are good stocks to hold for the next few months and beyond.

GSK : 38.39 (-2.41%)
BIIB : 291.71 (-0.51%)
JNJ : 164.36 (-0.30%)
PFE : 43.94 (-0.57%)
NVO : 100.70 (-1.37%)
LLY : 231.68 (-0.22%)
BNTX : 333.48 (-5.53%)
3 Big Drug/Biotech Outperformers Worth Keeping an Eye On

Eli Lilly (LLY), Pfizer (PFE) and Novo Nordisk (NVO) are three large drugmakers that have outperformed the industry and are good stocks to hold for the next few months and beyond.

GSK : 38.39 (-2.41%)
BIIB : 291.71 (-0.51%)
JNJ : 164.36 (-0.30%)
PFE : 43.94 (-0.57%)
NVO : 100.70 (-1.37%)
LLY : 231.68 (-0.22%)
BNTX : 333.48 (-5.53%)
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

NVO : 100.70 (-1.37%)
Here is Why Prothena (PRTA) is Up More Than 155% in Three Months

Prothena (PRTA) surges substantially in the past three months on solid prospects of its AD candidates following Biogen???s AD drug approval.

BIIB : 291.71 (-0.51%)
BMY : 60.23 (-0.66%)
NVO : 100.70 (-1.37%)
PRTA : 75.32 (-4.53%)
Top Research Reports for Berkshire Hathaway, Cisco & Novo Nordisk

Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Cisco Systems, Inc. (CSCO), and Novo Nordisk A/S (NVO).

BA : 221.39 (+0.13%)
TXN : 200.65 (+1.00%)
NVO : 100.70 (-1.37%)
CSCO : 56.73 (+0.07%)
DE : 349.25 (-0.64%)
BRK.B : 277.87 (-0.09%)
Enterin Announces Appointment of Alan Moses to Its Scientific Advisory Board

/PRNewswire/ -- , a privately held, -based, clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative and metabolic diseases, announces the appointment of , MD, to its...

NVO : 100.70 (-1.37%)
Ceurens to debut as stagiaire for Team Novo Nordisk at Tour of Denmark

/PRNewswire-PRWeb/ -- Young Belgian puncheur Robbe Ceurens is set to make his first appearance for the Team Novo Nordisk professional team at the upcoming PostNord Danmark Rundt – Tour of next week,...

NVO : 100.70 (-1.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural...

See More

Key Turning Points

3rd Resistance Point 102.60
2nd Resistance Point 102.09
1st Resistance Point 101.40
Last Price 100.70
1st Support Level 100.20
2nd Support Level 99.69
3rd Support Level 99.00

See More

52-Week High 107.24
Last Price 100.70
Fibonacci 61.8% 90.42
Fibonacci 50% 85.23
Fibonacci 38.2% 80.04
52-Week Low 63.22

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar